Correlations of CSF tau and amyloid levels with Alzheimer pathology in neuropathologically verified dementia with Lewy bodies

Staging of Lewy-related pathology in dementia

(2012) Hans Brunnström et al.   CLINICAL NEUROPATHOLOGY

Comparison of four neuropathological scales for Alzheimer’s disease

(2011) H. Brunnström et al.   CLINICAL NEUROPATHOLOGY

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

(2011) Brit Mollenhauer et al.   LANCET NEUROLOGY

Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses

(2010) Hans Brunnström et al.   Alzheimers & Dementia

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

CSF biomarkers predict a more malignant outcome in Alzheimer disease

(2010) A. K. Wallin et al.   NEUROLOGY

Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

(2009) Tero Tapiola et al.   ARCHIVES OF NEUROLOGY

Cerebrospinal Fluid Total Tau Is Associated with Shorter Survival in Dementia with Lewy Bodies

(2009) Fredrik Boström et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia

(2007) Sebastiaan Engelborghs et al.   NEUROBIOLOGY OF AGING